company background image
MPCI logo

Memphis Pharmaceuticals & Chemical Industries CASE:MPCI Stock Report

Last Price

ج.م72.96

Market Cap

ج.م410.4m

7D

0%

1Y

127.3%

Updated

23 Jun, 2024

Data

Company Financials

Memphis Pharmaceuticals & Chemical Industries

CASE:MPCI Stock Report

Market Cap: ج.م410.4m

MPCI Stock Overview

A drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally.

MPCI fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends4/6

Memphis Pharmaceuticals & Chemical Industries Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Memphis Pharmaceuticals & Chemical Industries
Historical stock prices
Current Share Priceج.م72.96
52 Week Highج.م139.99
52 Week Lowج.م29.00
Beta0.23
11 Month Change-12.86%
3 Month Change-26.84%
1 Year Change127.29%
33 Year Change160.11%
5 Year Change727.21%
Change since IPO141.42%

Recent News & Updates

Recent updates

Shareholder Returns

MPCIEG PharmaceuticalsEG Market
7D0%0%0%
1Y127.3%20.5%47.0%

Return vs Industry: MPCI exceeded the EG Pharmaceuticals industry which returned 20.5% over the past year.

Return vs Market: MPCI exceeded the EG Market which returned 47% over the past year.

Price Volatility

Is MPCI's price volatile compared to industry and market?
MPCI volatility
MPCI Average Weekly Movement6.3%
Pharmaceuticals Industry Average Movement4.8%
Market Average Movement7.3%
10% most volatile stocks in EG Market10.5%
10% least volatile stocks in EG Market3.7%

Stable Share Price: MPCI's share price has been volatile over the past 3 months.

Volatility Over Time: MPCI's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1940n/aBassem Abdullahwww.memphis.com.eg

Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal health products in powder form, as well as in oral and injectable solution forms.

Memphis Pharmaceuticals & Chemical Industries Fundamentals Summary

How do Memphis Pharmaceuticals & Chemical Industries's earnings and revenue compare to its market cap?
MPCI fundamental statistics
Market capج.م410.40m
Earnings (TTM)ج.م221.75m
Revenue (TTM)ج.م887.94m

1.9x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MPCI income statement (TTM)
Revenueج.م887.94m
Cost of Revenueج.م583.32m
Gross Profitج.م304.62m
Other Expensesج.م82.88m
Earningsج.م221.75m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)39.42
Gross Margin34.31%
Net Profit Margin24.97%
Debt/Equity Ratio317.3%

How did MPCI perform over the long term?

See historical performance and comparison

Dividends

2.7%

Current Dividend Yield

5%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.